119 related articles for article (PubMed ID: 6685196)
1. [Determination of urinary immunosuppressive acidic protein in cancer patients].
Hirayama T; Tamura K; Kikuchi S; Shibata Y; Kanno H; Sato Y; Ishida N; Kikuchi K
Gan No Rinsho; 1983 Sep; 29(11):1323-9. PubMed ID: 6685196
[TBL] [Abstract][Full Text] [Related]
2. [Urine levels of immunosuppressive acidic protein in patients with or without cancer].
Hirayama T
Nihon Geka Gakkai Zasshi; 1985 Oct; 86(10):1379-87. PubMed ID: 4079895
[TBL] [Abstract][Full Text] [Related]
3. [Clinical evaluation of the serum level of immunosuppressive acidic protein (IAP) and immunosuppressive substance (IS) in gastric cancer patients].
Sakita M; Yamane T; Kasuga M; Torii T; Imai H; Kageyama N; Fujita Y; Majima S
Gan To Kagaku Ryoho; 1982 Oct; 9(10):1755-64. PubMed ID: 7184372
[TBL] [Abstract][Full Text] [Related]
4. [Variations in the level of immunosuppressive acidic protein in patients with gynecologic tumors and pregnant women].
Sawada M; Okudaira Y; Matsui Y; Miyoshi Y; Takayama K; Shimizu Y; Miura S
Gan To Kagaku Ryoho; 1983 Aug; 10(8):1823-30. PubMed ID: 6882005
[TBL] [Abstract][Full Text] [Related]
5. [Clinical investigation of serum immunosuppressive acidic protein (IAP) in patients with gastric cancer].
Kageyama T; Oyabu H; Ohshiba S
Gan No Rinsho; 1986 Sep; 32(11):1416-20. PubMed ID: 3773269
[TBL] [Abstract][Full Text] [Related]
6. [Serum levels of immunosuppressive acidic protein (IAP) in various disease states and their clinical significance].
Kikuchi S
Nihon Geka Gakkai Zasshi; 1984 Apr; 85(4):283-99. PubMed ID: 6749105
[TBL] [Abstract][Full Text] [Related]
7. [Clinical significance of measurement of immunosuppressive acidic protein (IAP) in lung cancer].
Kondo H; Seno N; Matsuo S; Otagaki S; Matsuki T; Hatayama T
Gan To Kagaku Ryoho; 1983 Oct; 10(10):2163-70. PubMed ID: 6625623
[TBL] [Abstract][Full Text] [Related]
8. [Urine levels of polyamine in patients with or without cancer].
Tsunoda A
Nihon Geka Gakkai Zasshi; 1987 Jul; 88(7):816-25. PubMed ID: 3670267
[TBL] [Abstract][Full Text] [Related]
9. Serum immunosuppressive acidic protein levels in patients with severe acute pancreatitis.
Shinzeki M; Ueda T; Takeyama Y; Yasuda T; Sawa H; Nakajima T; Matsumoto I; Fujita T; Ajiki T; Fujino Y; Kuroda Y
Pancreas; 2007 Nov; 35(4):327-33. PubMed ID: 18090238
[TBL] [Abstract][Full Text] [Related]
10. Urinary tissue factor levels in patients with breast and colorectal cancer.
Lwaleed BA; Chisholm M; Francis JL
J Pathol; 1999 Feb; 187(3):291-4. PubMed ID: 10398081
[TBL] [Abstract][Full Text] [Related]
11. [The significance of determination of urinary trypsin inhibitor related antigen in patients with cancer of the digestive organs].
Nishino N
Nihon Gan Chiryo Gakkai Shi; 1990 Mar; 25(3):603-12. PubMed ID: 2351853
[TBL] [Abstract][Full Text] [Related]
12. [Daily excretion of melatonin in patients with cancer of the stomach and large intestine].
Kvetnoĭ IM; Levin IM
Vopr Onkol; 1987; 33(11):29-32. PubMed ID: 3686918
[TBL] [Abstract][Full Text] [Related]
13. [Examinations of the urine of cancer patients].
Matsuoka H
Iryo; 1967 Oct; 21(10):1193-7. PubMed ID: 5590372
[No Abstract] [Full Text] [Related]
14. Increased incidence of matrix metalloproteinases in urine of cancer patients.
Moses MA; Wiederschain D; Loughlin KR; Zurakowski D; Lamb CC; Freeman MR
Cancer Res; 1998 Apr; 58(7):1395-9. PubMed ID: 9537238
[TBL] [Abstract][Full Text] [Related]
15. ELISA measurement for urinary 3-hydroxyproline-containing peptides and its preliminary application to healthy persons and cancer patients.
Saito J; Imamura Y; Itoh J; Matsuyama S; Maruta A; Hayashi T; Sato A; Wada N; Kashiwazaki K; Inagaki Y; Watanabe T; Kitagawa Y; Okazaki I
Anticancer Res; 2010 Mar; 30(3):1007-14. PubMed ID: 20393028
[TBL] [Abstract][Full Text] [Related]
16. [Urinary excretion of asparagne and aspartate in control subjects and patients with cancer before and after treatment with K-Mg-aspartate].
Kronberger L; Fink E; Daill M; Schindler R
Wien Klin Wochenschr; 1972 Nov; 84(45):722-5. PubMed ID: 4641568
[No Abstract] [Full Text] [Related]
17. Serum immunosuppressive acidic protein reflects systemic deterioration of colorectal cancer patient condition.
Toiyama Y; Miki C; Inoue Y; Okugawa Y; Koike Y; Watanabe H; Yokoe T; Hiro J; Ojima E; Tanaka K; Kusunoki M
J Surg Oncol; 2008 Apr; 97(5):404-8. PubMed ID: 18181167
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppressive acidic protein (IAP) and squamous cell carcinoma antigen (SCC) in patients with cervical cancer.
Battaglia F; Scambia G; Panici PB; Castelli M; Ferrandina G; Foti E; Amoroso M; D'Andrea G; Mancuso S
Gynecol Oncol; 1994 May; 53(2):176-82. PubMed ID: 8188076
[TBL] [Abstract][Full Text] [Related]
19. [Immunosuppressive acidic protein (IAP) in gynecologic malignant tumors and its relationship with other immunosuppressive substances and cell-mediated immunity].
Takada M
Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt):237-44. PubMed ID: 6881975
[TBL] [Abstract][Full Text] [Related]
20. [Study of immunosuppressive acidic protein (IAP) in patients with renal cell cancer].
Shibayama T; Nakazono M; Koyama Y; Deguchi N; Baba S; Jitsukawa S; Murai M; Tazaki H
Gan No Rinsho; 1984 May; 30(5):481-6. PubMed ID: 6727048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
